AUTOTAC Bio
Latest round
- Series B
Last raised
- Apr 2020
Total raised
- $17M
Investors
- 10
About AUTOTAC Bio
Based in Seoul, South Korea, and founded in 2018, AUTOTECH Bio is a pharmaceutical company that focuses on the development of protein target decomposition platform technology. The company's CEO Yong Tae Kwon graduated from Seoul National University and was a senior scientist at the California Institute of Technology. The company provides innovative drug platforms based on targeted protein degradation using autophagy in the human body. It can be applied to various cancers, degenerative brain diseases, autoimmune and metabolic diseases, and rare and incurable diseases. The company's pipelines include neurodegeneration, amyloidosis, cancer, muscular dystrophy, infectious disease, and metabolic disease.
Who invested in AUTOTAC Bio
10 investors across 1 round
See all investors in AUTOTAC Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 9, 2020
Amount
$17M
Investors
Questions about AUTOTAC Bio
Who invested in AUTOTAC Bio?
AUTOTAC Bio has 10 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AUTOTAC Bio raised?
AUTOTAC Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AUTOTAC Bio last raise money?
AUTOTAC Bio's most recent round on record is a Series B, in Apr 2020.
What does AUTOTAC Bio do?
Based in Seoul, South Korea, and founded in 2018, AUTOTECH Bio is a pharmaceutical company that focuses on the development of protein target decomposition platform technology.
Where is AUTOTAC Bio headquartered?
AUTOTAC Bio is headquartered in Seoul, South Korea.
Which VCs invest in companies like AUTOTAC Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare it companies at AUTOTAC Bio's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like AUTOTAC Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.